Roche's Columvi (Glofitamab) Regimen Receives the EC’s Approval to Treat R/R Diffuse Large B-Cell Lymphoma (DLBCL)
Shots: The EC has granted full approval to Columvi + GemOx for ASCT-ineligible r/r...
Shots: The EC has granted full approval to Columvi + GemOx for ASCT-ineligible r/r...
Shots: The US FDA has approved Opdivo + Yervoy as 1L therapy to treat inoperable o...
Shots: Health Canada has approved Imfinzi monotx. for the treatment of LS-SCLC adu...
Shots: The US FDA has approved Vyvgart Hytrulo (efgartigimod alfa & hyaluronid...
Shots: The US FDA has granted full approval to Vitrakvi for adults & pediatric...
Shots: The EC has approved Datroway to treat unresectable or metastatic HR+/HER2-...
Incisive News in 3 Shots.
Modal body text goes here.